Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Slate Path Capital LP | 704.1K | $1.0M | 7.51% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 344.4K | -- | 3.67% | -326 | 2026-06-30 |
| American Financial Group Inc | 223.7K | -- | 2.38% | -- | 2026-06-30 |
| UBS Group AG | 111.1K | -- | 1.18% | +60.7K | 2026-06-30 |
| Silvercrest Asset Management Group LLC | 101.0K | -- | 1.08% | -- | 2026-06-30 |
| BlackRock, Inc. | 95.5K | -- | 1.02% | -292.6K | 2026-06-30 |
| Renaissance Technologies LLC | 91.4K | -- | 0.97% | -691 | 2026-06-30 |
| Geode Capital Management, LLC | 90.3K | -- | 0.96% | -92.0K | 2026-06-30 |
| Morgan Stanley | 77.8K | -- | 0.83% | +5.0K | 2026-06-30 |
| Duncan Williams Asset Management, LLC | 63.2K | -- | 0.67% | -- | 2026-06-30 |
